Taho Pharmaceuticals Ltd. (TWSE: 6467)
Health Care · Pharmaceuticals · TW
NT$224.50
-2.81% today · +30.9% 1Y
Public summary
A free snapshot of Taho Pharmaceuticals Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Taho Pharmaceuticals Ltd. (TWSE: 6467) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $357.09M.
Over the last twelve months the share price has gained 30.9%, trading between 100.50 and 302.00.
Tweenvest scores Taho Pharmaceuticals Ltd. across four factors: quality 36/100, value 92/100. Its strongest factor is value.
6467 price history
Key figures
- Market cap
- $357.09M
- Revenue (TTM)
- $196.35K
- P/E
- -46.94
- EPS
- -4.59
- Dividend yield
- —
- Beta (5Y)
- -0.74
- 52-week high
- NT$302.00
- 52-week low
- NT$100.50
- Avg volume (3M)
- —
- Shares outstanding
- 52.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Boiron SAENXTPA: BOI | $363.98M | €19.10 | 0.00% |
| Unichem Laboratories LimitedBSE: 506690 | $362.79M | Rs485.85 | -2.45% |
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $358.87M | CN¥5.15 | -1.15% |
| Abbott Laboratories (Pakistan) LimitedKASE: ABOT | $357.24M | PKRs1,009.02 | +0.35% |
| Egyptian International Pharmaceutical Industries CompanyCASE: PHAR | $354.36M | EGP112.21 | -0.24% |
| Solara Active Pharma Sciences LimitedNSEI: SOLARA | $352.90M | Rs689.65 | +1.98% |
| Vireo Growth Inc.CNSX: VREO | $346.92M | CA$9.45 | -2.07% |
| Zhejiang Xinguang Pharmaceutical Co., Ltd.SZSE: 300519 | $346.36M | CN¥14.45 | -3.41% |